What is the price target for MDT stock?
37 analysts have analysed MDT and the average price target is 111.21 USD. This implies a price increase of 33.59% is expected in the next year compared to the current price of 83.245.
NYSE:MDT • IE00BTN1Y115
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEDTRONIC PLC (MDT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-22 | UBS | Maintains | Neutral -> Neutral |
| 2026-04-15 | Truist Securities | Maintains | Hold -> Hold |
| 2026-04-13 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-04-09 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-04-07 | Citigroup | Maintains | Buy -> Buy |
| 2026-04-06 | Argus Research | Maintains | Buy -> Buy |
| 2026-04-06 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-04-01 | Barclays | Maintains | Overweight -> Overweight |
| 2026-04-01 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2026-03-26 | Needham | Reiterate | Buy -> Buy |
| 2026-03-10 | Needham | Reiterate | Buy -> Buy |
| 2026-02-18 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-18 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-02-18 | Baird | Maintains | Neutral -> Neutral |
| 2026-02-17 | Needham | Maintains | Buy -> Buy |
| 2026-02-13 | Barclays | Reiterate | Overweight -> Overweight |
| 2026-02-09 | Needham | Upgrade | Hold -> Buy |
| 2026-01-09 | Bernstein | Maintains | Outperform -> Outperform |
| 2026-01-08 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-06 | William Blair | Upgrade | Market Perform -> Outperform |
| 2025-12-18 | Truist Securities | Maintains | Hold -> Hold |
| 2025-11-20 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-20 | Truist Securities | Maintains | Hold -> Hold |
| 2025-11-19 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-19 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 31.227B -1.45% | 32.364B 3.64% | 33.537B 3.62% | 36.525B 8.91% | 38.913B 6.54% | 40.801B 4.85% | 41.536B 1.80% | 43.769B 5.38% | |
| EBITDA YoY % growth | 9.043B -5.93% | 8.768B -3.04% | 9.436B 7.62% | 10.344B 9.62% | 11.181B 8.09% | 12.025B 7.55% | 12.403B 3.14% | 13.227B 6.64% | |
| EBIT YoY % growth | 6.346B -8.11% | 6.121B -3.55% | 6.575B 7.42% | 9.162B 39.35% | 9.85B 7.51% | 10.551B 7.12% | 11.068B 4.90% | 11.886B 7.39% | |
| Operating Margin | 20.32% | 18.91% | 19.61% | 25.08% | 25.31% | 25.86% | 26.65% | 27.16% | |
| EPS YoY % growth | 5.30 -5.69% | 5.21 -1.70% | 5.50 5.57% | 5.66 2.83% | 6.13 8.42% | 6.59 7.55% | 7.13 8.12% | 7.70 8.04% |
All data in USD
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.61 -0.74% | 1.40 10.92% | 1.44 6.05% | 1.48 8.89% | 1.80 11.74% | 1.49 6.96% | 1.53 5.83% | 1.59 7.30% | 1.97 9.89% |
| Revenue Q2Q % growth | 9.744B 9.15% | 9.463B 10.82% | 9.563B 6.72% | 9.609B 6.57% | 10.25B 5.19% | 9.903B 4.65% | 10.075B 5.35% | 10.17B 5.84% | 10.896B 6.30% |
| EBITDA Q2Q % growth | 3.014B -35.31% | 2.539B 11.07% | 2.647B -17.07% | 2.681B -31.95% | 3.198B 6.10% | 2.749B 8.27% | 2.797B 5.67% | 2.945B 9.85% | 3.384B 5.82% |
| EBIT Q2Q % growth | 2.664B 48.16% | 2.261B 47.01% | 2.343B 37.90% | 2.39B 40.75% | 2.886B 8.33% | 2.45B 8.36% | 2.479B 5.80% | 2.616B 9.46% | 3.155B 9.32% |
All data in USD
37 analysts have analysed MDT and the average price target is 111.21 USD. This implies a price increase of 33.59% is expected in the next year compared to the current price of 83.245.
MEDTRONIC PLC (MDT) will report earnings on 2026-06-03, after the market close.
The consensus EPS estimate for the next earnings of MEDTRONIC PLC (MDT) is 1.61 USD and the consensus revenue estimate is 9.74B USD.
The number of analysts covering MEDTRONIC PLC (MDT) is 37.